Jin-Young Huh, Byeong-Ho Jeong, Ho Il Yoon, Hojoong Kim, Young-Jae Cho, Changhwan Kim, Seung Jun Lee, Hwan Hee Kim, Seung Won Ra, Ye Jin Lee, Beong Ki Kim, Sung Kyoung Kim, Ki Hyun Seo, Sei Won Lee
BACKGROUND: Endobronchial valve (EBV) therapy, a validated method for bronchoscopic lung volume reduction (BLVR) in severe emphysema, has been explored for persistent air-leak (PAL) management. However, its effectiveness and safety in the Asian population require further real-world evaluation. In this study, we assessed the outcomes of treatment with EBV within this demographic. METHODS: We conducted a retrospective analysis of medical records from 11 Korean centers...
April 3, 2024: BMC Pulmonary Medicine